Product

Company

NCT02447900·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Steen Riisgaard Mortensen

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Age \> 18 years old
Histologically confirmed non-small cell lung cancer (NSCLC)
Stage T1-4N1-3M0
Performance status ≤ 2
Inoperable
FEV1 ≥ 1 l
Ability to hold deep inspiration breathhold for \> 15 seconds
Accepting treatment at Rigshospitalet
Eligible for concomitant chemo-radiotherapy
If a woman is of childbearing potential, a negative pregnancy test must be documented
Ability to understand the given information
Signed written consent for inclusion into the study

The record

StatusCompleted

PhasePhase 1

Taking part15

StartedJul 2014

UpdatedJan 29, 2021

Conditions

Where1

Clareo Health | Marker Guided Breathhold Radiotherapy in NSCLC